Details for Patent: RE46762
✉ Email this page to a colleague
Which drugs does patent RE46762 protect, and when does it expire?
Patent RE46762 protects VEKLURY and is included in one NDA.
Protection for VEKLURY has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eighty-six patent family members in thirty-two countries.
Summary for Patent: RE46762
| Title: | 1'-substituted carba-nucleoside analogs for antiviral treatment |
| Abstract: | Provided are pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 1' position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections. |
| Inventor(s): | Butler; Thomas (Carmel, CA), Cho; Aesop (Mountain View, CA), Kim; Choung U. (San Carlos, CA), Parrish; Jay P. (El Dorado Hills, CA), Saunders; Oliver L. (Clovis, CA), Zhang; Lijun (Los Altos Hills, CA) |
| Assignee: | GILEAD SCIENCES, INC (Foster City, CA) |
| Application Number: | 15/288,271 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent RE46762
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | VEKLURY | remdesivir | POWDER;INTRAVENOUS | 214787-001 | Oct 22, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Gilead Sciences Inc | VEKLURY | remdesivir | SOLUTION;INTRAVENOUS | 214787-002 | Oct 22, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE46762
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2937350 | ⤷ Sign Up | LUC00193 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2937350 | ⤷ Sign Up | PA2020539 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2937350 | ⤷ Sign Up | CA 2020 00060 | Denmark | ⤷ Sign Up |
| European Patent Office | 2937350 | ⤷ Sign Up | CR 2020 00060 | Denmark | ⤷ Sign Up |
| European Patent Office | 2937350 | ⤷ Sign Up | PA2020539,C2937350 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2937350 | ⤷ Sign Up | C20200043 00387 | Estonia | ⤷ Sign Up |
| African Regional IP Organization (ARIPO) | 3076 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
